MetLife Investment Management, LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$1,446,132
-9.7%
49,0880.0%0.01%
-8.3%
Q2 2023$1,601,251
+5.9%
49,088
+14.2%
0.01%
+9.1%
Q1 2023$1,512,361
-23.2%
42,9770.0%0.01%
-31.2%
Q4 2022$1,969,206
-5.4%
42,9770.0%0.02%
-11.1%
Q3 2022$2,082,236
+24.3%
42,977
+0.8%
0.02%
+28.6%
Q2 2022$1,675,483
+6.9%
42,644
+0.1%
0.01%
+40.0%
Q1 2022$1,567,812
+19.3%
42,592
+47.7%
0.01%
-9.1%
Q4 2021$1,313,980
+27.5%
28,8280.0%0.01%
+10.0%
Q3 2021$1,030,313
+104.4%
28,828
+13.2%
0.01%
+100.0%
Q2 2021$504,190
-14.9%
25,4770.0%0.01%
-16.7%
Q1 2021$592,595
+0.2%
25,477
-10.5%
0.01%0.0%
Q4 2020$591,295
-4.0%
28,4550.0%0.01%
-14.3%
Q3 2020$616,051
-0.8%
28,455
+8.0%
0.01%0.0%
Q2 2020$621,022
+99.9%
26,3480.0%0.01%
+75.0%
Q1 2020$310,643
+11.1%
26,3480.0%0.00%
+33.3%
Q4 2019$279,552
-6.8%
26,3480.0%0.00%0.0%
Q3 2019$299,840
+1.2%
26,3480.0%0.00%0.0%
Q2 2019$296,413
+95.8%
26,348
+40.8%
0.00%
+50.0%
Q1 2019$151,412
+28.0%
18,7160.0%0.00%
+100.0%
Q4 2018$118,285
-35.8%
18,7160.0%0.00%
-50.0%
Q3 2018$184,353
+18.9%
18,7160.0%0.00%0.0%
Q2 2018$155,000
+14.8%
18,7160.0%0.00%0.0%
Q1 2018$135,000
-11.8%
18,7160.0%0.00%0.0%
Q4 2017$153,00018,7160.00%
Other shareholders
CYTOKINETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
BVF INC/IL 2,106,989$14,159,0002.50%
Healthcare Value Capital, LLC 100,000$672,0000.71%
First Light Asset Management, LLC 218,792$1,470,0000.69%
IRONWOOD INVESTMENT MANAGEMENT LLC 435,202$2,925,0000.67%
TFS CAPITAL LLC 899,951$6,048,0000.59%
SPHERA FUNDS MANAGEMENT LTD. 422,250$2,838,0000.28%
ALGERT GLOBAL LLC 73,181$492,0000.27%
LANSDOWNE PARTNERS (UK) LLP 2,321,865$15,603,0000.13%
Leisure Capital Management 17,567$118,0000.12%
Rotella Capital Management, Inc. 15,778$106,0000.09%
View complete list of CYTOKINETICS INC shareholders